On September 6, the 2023 China International Fair for Trade in Services concluded successfully in Beijing. This fair focused on the annual theme of "Openness Leads Development, Cooperation Wins the Future" and attracted the world's leading innovative technologies and scientific research results to appear at the event. A total of nearly 280,000 people attended the event.
As a leading company in precision oncology medicine in China, Shihe Gene was invited to participate in the exhibition and appeared in the health service special exhibition area with the theme of "Based in China, Serving the World". Many industry experts, pharmaceutical companies and media representatives came to learn about precise diagnosis and treatment of tumors. In addition, the company was rated as an "Excellent Demonstration Enterprise" in the health sector.
Innovation drives technology to lead the way
Health and hygiene services are one of the nine major themes of this CIFTIS. The exhibition area is located in Hall 3 of Shougang Park. With the theme of "Technology empowers health innovation to lead the future", it gathers many well-known medical institutions and leading companies at home and abroad. Based on the linkage of the "three medicines" of medical care, medical insurance, and medicine, it demonstrates new trends in science and technology and innovation in the field of health and hygiene.
Over the years, Shihe Gene has always adhered to R&D and innovation, and many of its core technologies and products are domestic firsts. In 2018, the independently developed Yishengkang 6 gene mutation detection kit passed the national NMPA innovative medical device approval for listing, and won the second prize of the 2020 Jiangsu Province Science and Technology Award. At this CIFTIS, Shihe Gene presented its products for the full cycle of precise tumor diagnosis and treatment, from solid tumors to hematological tumors, from late-stage companion diagnosis to perioperative recurrence monitoring to early screening of tumors in healthy people, comprehensively demonstrating the company's expertise in precision tumor diagnosis and treatment. Cutting-edge technologies and innovations in the medical field.
"Shihe Hawkeye" makes its grand debut
Shihe's breakthrough innovative product for early cancer screening, Eagle Eye, made its debut at the Service Trade Fair, attracting enthusiastic attention from the guests attending the event. Shihe's Eagle Eye pan-cancer early screening product uses the MERCURY multi-omics tumor early screening technology independently developed by Shihe. It only requires a small amount of peripheral blood to screen nine high-risk cancers at once, including lung cancer, liver cancer, and intestinal cancer. Once an abnormal signal is discovered, Shihe Eagle Eye can also locate the specific part of the signal source, thereby shortening the time and process of tumor screening and diagnosis. The sensitivity and specificity of detecting early tumors have reached the world's advanced level. At the beginning of the year, Shihe Eagle Eye pan-cancer early screening kit obtained the EU CE certification.
Based in China and going global
In order to enable high-quality genetic testing technology to serve foreign patients, Shihe Gene launched a globalization strategy in 2017 and actively expanded overseas markets and international cooperation. In recent years, the company has signed hundreds of millions of orders with internationally renowned pharmaceutical companies, reached technology export transfer cooperation with a number of large overseas medical institutions, participated in a number of international clinical trials, and 5 self-developed innovative test kits have obtained EU CE certification. At present, the company's services and sales have expanded to North America, the Middle East, Europe and Southeast Asia .
This Service Trade Fair has gathered many advantageous resources in the global health field. During the conference, Shihe Gene conducted face-to-face cooperation negotiations with customers from many countries. We will firmly seize the opportunity of the era of China's expansion of opening up and international cooperation, make full use of the bridging role of the international economic and trade exchange platform of the CIFTIS, and promote China's precision testing technology to the world.